Dabigatran-related platelet thrombin response during triple anti-thrombotic therapy: A matter of time? [electronic resource]
- Thrombosis research Jan 2017
- 62-63 p. digital
Publication Type: Letter
1879-2472
10.1016/j.thromres.2016.11.013 doi
Aged Anticoagulants--therapeutic use Antithrombins--therapeutic use Blood Platelets--drug effects Dabigatran--therapeutic use Female Humans Male Peptide Fragments--metabolism Percutaneous Coronary Intervention--adverse effects Platelet Aggregation--drug effects Platelet Aggregation Inhibitors--therapeutic use Thrombin--metabolism Thrombosis--drug therapy